Afya (NASDAQ:AFYA) Hits New 12-Month Low - Time to Sell?

Afya logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Afya Limited (NASDAQ:AFYA - Get Free Report)'s share price hit a new 52-week low on Friday. The company traded as low as $9.52 and last traded at $9.7050, with a volume of 15,048 shares changing hands. The stock had previously closed at $10.15.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AFYA. Wall Street Zen lowered Afya from a "buy" rating to a "hold" rating in a research report on Monday. Weiss Ratings downgraded Afya from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Thursday, October 29th. Bradesco Corretora raised Afya to an "outperform" rating and set a $17.00 price target on the stock in a research note on Thursday, September 24th. Zacks Research lowered Afya from a "hold" rating to a "strong sell" rating in a research note on Tuesday, November 3rd. Finally, Morgan Stanley upgraded Afya from an "underweight" rating to an "equal weight" rating and set a $12.60 price target on the stock in a report on Thursday, November 5th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Afya currently has an average rating of "Hold" and an average target price of $15.18.

Check Out Our Latest Analysis on Afya

Afya Trading Down 0.6%

The business's 50 day simple moving average is $12.50 and its 200-day simple moving average is $13.90. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.08 and a quick ratio of 2.08. The stock has a market capitalization of $905.34 million, a P/E ratio of 5.68, a PEG ratio of 1.63 and a beta of 0.43.

Insider Activity at Afya

In related news, insider Santos Welder Ferreira sold 4,161 shares of the company's stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the sale, the insider owned 35,000 shares in the company, valued at approximately $465,500. This represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Afya

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AFYA. Public Employees Retirement System of Ohio bought a new stake in shares of Afya in the 2nd quarter valued at about $67,000. R Squared Ltd raised its position in shares of Afya by 37.0% in the 3rd quarter. R Squared Ltd now owns 60,114 shares of the company's stock valued at $724,000 after acquiring an additional 16,250 shares during the period. Dodge & Cox raised its position in shares of Afya by 33.5% in the 3rd quarter. Dodge & Cox now owns 68,487 shares of the company's stock valued at $825,000 after acquiring an additional 17,200 shares during the period. Entropy Technologies LP acquired a new stake in shares of Afya in the 3rd quarter valued at approximately $246,000. Finally, Engineers Gate Manager LP bought a new position in Afya during the 2nd quarter worth approximately $325,000. Institutional investors own 88.02% of the company's stock.

Afya Company Profile

(Get Free Report)

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines